Salivary NLRP3 inflammasome as a promising biomarker for palatal mucosa healing in diabetes mellitus: A pilot study
Journal of Periodontology · 2026
DOI: 10.1002/jper.70149 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Periodontology, 2026. Verfasst von Manuela Maria Viana Miguel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Oral Health Research, College of Dentistry, University of Kentucky, Lexington, Kentucky, USA. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Diabetes Mellitus, Type 2, Wound Healing, Saliva. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Igniting Research Collaborations - University of Kentucky, Dr. Gene Lewis Fellowship award - University of Kentucky, Brazilian Federal Agency for Support and Evaluation of Graduate Education.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
The NOD‐like receptor family pyrin domain‐containing protein 3 (NLRP3) inflammasome is a protein complex that regulates IL‐1β activation. Despite its known role in dermal healing, its involvement in oral mucosal healing remains poorly understood.
Methods
Twenty‐four subjects, including 12 with Type 2 diabetes mellitus (T2DM) and 12 normoglycemic controls (C), underwent a surgical procedure for mucogingival defect treatment in which a graft was harvested from the palate. The palatal wound was assessed for remaining wound area (RWA) and epithelialization (EPT) until 3 months. Wound exudate was collected on days 3 and 7 post‐operatively to analyze inflammatory biomarkers, proteinases, and growth factors. NLRP3, PYCARD, CASPASE‐1, and interleukin‐1beta (IL‐1β) salivary levels were assessed preoperatively and 7 days post‐surgery.
Results
Lower EPT rates and greater RWA were observed in T2DM compared to Control on days 7 and 14 postoperatively. Higher MMP‐9 concentration was detected in T2DM subjects on days 3 and 7 post‐surgery ( p < 0.05). Salivary NLRP3 and PYCARD increased in the C group at 7 days post‐surgery ( p ≤ 0.04), whereas IL‐1β was higher over time in the T2DM group ( p = 0.003). At baseline, NLRP3 and PYCARD levels were higher in T2DM ( p ≤ 0.005), whereas PYCARD ( p = 0.01) and CASPASE‐1 ( p = 0.05) remained elevated at 7 days compared with C. A positive association between salivary NLRP3 levels with IL‐1β ( r = 0.46) and tumor necrosis factor‐alpha (TNF‐ α ) ( r = 0.47) from wound exudate on day 7 was observed. PYCARD levels associated with IL‐1β ( r = 0.48) and TNF‐ α ( r = 0.50) at the same time point. Principal component analysis of inflammasome‐related markers and wound biomarkers on day 7 suggested a potential impact on delayed wound closure by day 14.
Conclusion
The NLRP3 inflammasome may be a promising biomarker for T2DM‐related acute palatal healing due to its early upregulation and association with proinflammatory markers, with a potential impact on delayed wound closure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Oral Health Research, College of Dentistry, University of Kentucky, Lexington, Kentucky, USA.
- Institute of Science and Technology-São Paulo State University (Unesp), São José dos Campos, São Paulo, Brazil.
- Department of Oral Health Practice, Restorative Division, College of Dentistry, University of Kentucky, Lexington, Kentucky, USA.
- Department of Athletic Training and Clinical Nutrition, College of Health Sciences, University of Kentucky, Lexington, Kentucky, USA.
ORCID-Profile: Manuela Maria Viana Miguel, Ana Carolina Ferreira Bonafé, Ingrid Fernandes Mathias-Santamaria, D Travis Thomas, Luciana Macchion Shaddox, Mauro Pedrine Santamaria
Förderung
- Igniting Research Collaborations - University of Kentucky
- Dr. Gene Lewis Fellowship award - University of Kentucky
- Brazilian Federal Agency for Support and Evaluation of Graduate Education
- NCATS NIH HHS
- National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health
Zitieren
APA
Miguel, M. M. V., Bonafé, A. C. F., Mathias-Santamaria, I. F., Thomas, D. T., Shaddox, L. M., & Santamaria, M. P. (2026). Salivary NLRP3 inflammasome as a promising biomarker for palatal mucosa healing in diabetes mellitus: A pilot study. Journal of Periodontology. https://doi.org/10.1002/jper.70149
Vancouver
Miguel MMV, Bonafé ACF, Mathias-Santamaria IF, Thomas DT, Shaddox LM, Santamaria MP. Salivary NLRP3 inflammasome as a promising biomarker for palatal mucosa healing in diabetes mellitus: A pilot study. Journal of Periodontology. 2026. doi:10.1002/jper.70149
BibTeX
@article{Miguel2026,
author = {Miguel, Manuela Maria Viana and Bonafé, Ana Carolina Ferreira and Mathias-Santamaria, Ingrid Fernandes and Thomas, D Travis and Shaddox, Luciana Macchion and Santamaria, Mauro Pedrine},
title = {Salivary NLRP3 inflammasome as a promising biomarker for palatal mucosa healing in diabetes mellitus: A pilot study},
journal = {Journal of Periodontology},
year = {2026},
doi = {10.1002/jper.70149}
}
EUVIMED